...
首页> 外文期刊>Biomedical Research >Development of Radiometric Assays for Quantification of Enzyme Activities of the Key Enzymes of Thyroid Hormones Metabolism
【24h】

Development of Radiometric Assays for Quantification of Enzyme Activities of the Key Enzymes of Thyroid Hormones Metabolism

机译:定量测定甲状腺激素代谢关键酶的酶活性的放射测定方法的发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary We newly elaborated and adapted several radiometric enzyme assays for the determination of activities of the key enzymes engaged in the biosynthesis (thyroid peroxidase, TPO) and metabolic transformations (conjugating enzymes and iodothyronine deiodinases, IDs) of thyroid hormones (THs) in the thyroid gland and in peripheral tissues, especially in white adipose tissue (WAT). We also elaborated novel, reliable radiometric methods for extremely sensitive determination of enzyme activities of IDs of types 1, 2 and 3 in microsomal fractions of different rat and human tissues, as well as in homogenates of cultured mammalian cells. The use of optimized TLC separation of radioactive products from the unconsumed substrates and film-less autoradiography of radiochromatograms, taking advantage of storage phosphor screens, enabled us to determine IDs enzyme activities as low as 10-18 katals. In studies of the interaction of fluoxetine (Fluox) with the metabolism of THs, we applied adapted radiometric enzyme assays for iodothyronine sulfotransferases (ST) and uridine 5'-diphosphoglucuronyltransferase (UDP-GT). Fluox is the most frequently used representative of a new group of non-tricyclic antidepressant drugs – selective serotonin re-uptake inhibitors. We used the elaborated assays for quantification the effects of Fluox and for the assessment of the degree of potential induction of rat liver ST and/or UDP-GT enzyme activities by Fluox alone or in combination with T3. Furthermore, we studied possible changes in IDs activities in murine adipose tissue under the conditions that promoted either tissue hypertrophy (obesogenic treatment) or involution (caloric restriction), and in response to leptin, using our newly developed radiometric enzyme assays for IDs. Our results suggest that deiodinase D1 has a functional role in WAT, with D1 possibly being involved in the control of adipose tissue metabolism and/or accumulation of the tissue. Significant positive correlation between specific enzyme activity of D1 in WAT and plasma leptin levels was found. The newly developed and adapted radiometric enzyme assays proved to be very useful tools for studies of factors modulating THs metabolism, not only in model animals but also in clinical studies of human obesity.
机译:总结我们新拟定并改编了几种辐射酶测定法,用于测定参与甲状腺的甲状腺激素(THs)的生物合成(甲状腺过氧化物酶,TPO)和代谢转化(结合酶和碘甲状腺素脱碘酶,ID)的关键酶的活性腺和周围组织,尤其是白色脂肪组织(WAT)。我们还精心设计了新颖,可靠的辐射测定方法,用于极其灵敏地确定不同大鼠和人类组织的微粒体级分以及培养的哺乳动物细胞匀浆中1、2和3型ID的酶活性。利用优化的薄层色谱法从未消耗的底物中分离出放射性产物,并利用存储的荧光粉筛查技术,对放射性色谱图进行无膜放射自显影,使我们能够确定低至10-18 katals的IDs酶活性。在氟西汀(Fluox)与THs代谢相互作用的研究中,我们应用了碘化甲状腺素磺基转移酶(ST)和尿苷5'-二磷酸葡糖醛酸酰基转移酶(UDP-GT)的适应性辐射酶分析。 Fluox是一组新的非三环抗抑郁药(选择性5-羟色胺再摄取抑制剂)中最常用的代表。我们使用精心设计的测定法来定量Fluox的作用,并评估Fluox单独或与T3结合可能诱导大鼠肝ST和/或UDP-GT酶活性的程度。此外,我们使用新开发的ID辐射酶分析方法,研究了在促进组织肥大(促肥胖症治疗)或内卷(热量限制)并响应瘦素的条件下,鼠脂肪组织中ID活性的可能变化。我们的结果表明,脱碘酶D1在WAT中具有功能性作用,其中D1可能参与了脂肪组织代谢和/或组织蓄积的控制。发现在WAT中D1的比酶活性与血浆瘦素水平之间存在显着的正相关。事实证明,新开发和改编的辐射酶测定法不仅对模型动物而且在人类肥胖症的临床研究中都是研究调节THs代谢的因素的非常有用的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号